Therapeutic efficacy and safety of loratadine syrup in childhood atopic dermatitis treated with mometasone furoate 0.1 per cent cream

Journal of the Medical Association of Thailand

Volumn 85, Issue 4, 2002, Pages 482-487

  Chunharas, Amornsri ^a   Wisuthsarewong, Wanee ^b   Wananukul, Siriwan ^c   Viravan, Suchitra ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Atopic Dermatitis; Loratadine; Mometasone Furoate

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; ELOMET; EMOLLIENT AGENT; LORATADINE; MOMETASONE FUROATE; PLACEBO;

ANOREXIA; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRY SKIN; EDEMA; ERYTHEMA; FEMALE; HUMAN; LICHENOID ERUPTION; MALE; MULTICENTER STUDY; NAUSEA; PAPULE; PRESCHOOL CHILD; PRURITUS; SKIN DISEASE; SOMNOLENCE; SYRUP; TREATMENT PLANNING;

ADMINISTRATION, CUTANEOUS; ANTIPRURITICS; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DOSAGE FORMS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; LORATADINE; MALE; PREGNADIENEDIOLS;

EID: 0344555412     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Prevalence of allergy in schoolchildren
2. Efficacy and safety of topical steroids in pediatric atopic dermatitis
3. Comparison of mometasone furoate 0.1 per cent cream and hydrocortisone 1.0 per cent in the treatment of childhood atopic dermatitis
4. Mometasone furoate-elocon - A medium potency topical corticosteroid with favorable efficacy/safety profile
5. Comparison of the effect of mometasone furoate ointment 0.1 per cent and hydrocortisone ointment 0.1 per cent, on adrenocortical function in psoriasis patients
6. Once-daily 0.1 per cent mometasone furoate cream versus twice daily 0.1 per cent betametasone valerate cream in the treatment of a variety of dermatoses
7. Therapeutic effect of loratadine on pruritus in patients with atopic dermatitis
8. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic urticaria and eczema
9. Antihistamine therapy for treatment of allergic dermatoses
10. The UK working party's diagnostic criteria for atopic dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis
11. The UK working party's diagnostic criteria for atopic dermatitis. II. Observer variation of clinical diagnosis and signs of atopic dermatitis
12. The UK working party's diagnostic criteria for atopic dermatitis. III. Independent hospital validation
13. Topical mometasone